Chemokines in mesenchymal stem cell therapy for bone repair: A novel concept of recruiting mesenchymal stem cells and the possible cell sources

Modern Rheumatology

Volumn 21, Issue 2, 2011, Pages 113-121

  Ito, Hiromu ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Bone repair; Chemokine; Fracture; Mesenchymal stem cell; Migration

Indexed keywords

BLOOD VESSEL WALL; BONE GRAFT; BONE INJURY; BONE MARROW; BONE REMODELING; CELL MIGRATION; CIRCULATION; FRACTURE HEALING; HUMAN; MESENCHYMAL STEM CELL TRANSPLANTATION; MUSCLE; NONHUMAN; PERIOSTEUM; PRIORITY JOURNAL; REVIEW;

ANIMALS; BONE REGENERATION; CELL MOVEMENT; CHEMOKINES; FRACTURE HEALING; FRACTURES, BONE; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS;

EID: 79960110605     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-010-0357-8     Document Type: Review

References (68)

1. Goldring S, Gravallese E. Mechanisms of bone loss in inflammatory arthritis: Diagnosis and therapeutic implications. Arthritis Res. 2000;2:33-7. (Pubitemid 32223681)
2. Paget S. Steroids cause osteoporosis. Ann Rheum Dis. 2002; 61:1-3. (Pubitemid 34074828)
3. Caplan AI. Mesenchymal stem cells. J Orthop Res. 1991; 9:641-50.
4. Tavassoli M, Crosby WH. Transplantation of marrow to extramedullary sites. Science. 1968;161:54-6.
5. Freidenstein AJ. Osteogenic stem cells in bone marrow. In: Heerschem JNM, Kanis JA, editors. Bone and mineral research. Amsterdam: Elsevier; 1990. p. 243-72.
6. Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet. 1970;3:393-403.
7. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143-7. (Pubitemid 29282067)
8. Bianco P, Robey PG, Simmons PJ. Mesenchymal stem cells: Revisiting history, concepts, and assays. Cell Stem Cell. 2008; 2:313-9. (Pubitemid 351467394)
9. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663-76. (Pubitemid 44233629)
10. Miura K, Okada Y, Aoi T, Okada A, Takahashi K, Okita K, Nakagawa M, Koyanagi M, Tanabe K, Ohnuki M, Ogawa D, Ikeda E, Okano H, Yamanaka S. Variation in the safety of induced pluripotent stem cell lines. Nat Biotechnol. 2009; 27:743-5.
11. Thomas ED. Bone marrow transplantation: A review. Semin Hematol. 1999;36[4 Suppl 7]:95-103.
12. Tögel F, Westenfelder C. Adult bone marrow-derived stem cells for organ regeneration and repair. Dev Dyn. 2007;236:3321-31. (Pubitemid 350276389)
13. Castano-Izquierdo H, Alvarez-Barreto J, van den Dolder J, Jansen J, Mikos A, Sikavitsas V. Pre-culture period of mesenchymal stem cells in osteogenic media influences their in vivo bone forming potential. J Biomed Mater Res A. 2007;82:129-38. (Pubitemid 46906498)
14. Hernigou P, Poignard A, Beaujean F, Rouard H. Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells. J Bone Joint Surg Am. 2005;87:1430-7. (Pubitemid 40917741)
15. Kucia M, Ratajczak M. Stem cells as a two edged sword-from regeneration to tumor formation. J Physiol Pharmacol. 2006; 57[Suppl 7]:5-16. (Pubitemid 46548788)
16. Jones E, McGonagle D. Human bone marrow mesenchymal stem cells in vivo. Rheumatology (Oxford). 2008;47:126-31. (Pubitemid 351168218)
17. Nishimura T, Simmons DJ, Mainous EG. The origin of bone formed by heterotopic periosteal autografts. J Oral Maxillofac Surg. 1997;55:1265-8. (Pubitemid 27495055)
18. Nakahara H, Bruder SP, Haynesworth SE, Holecek JJ, Baber MA, Goldberg VM, Caplan AI. Bone and cartilage formation in diffusion chambers by subcultured cells derived from the periosteum. Bone. 1990;11:181-8. (Pubitemid 20359493)
19. Nakahara H, Goldberg VM, Caplan AI. Culture-expanded human periosteal-derived cells exhibit osteochondral potential in vivo. J Orthop Res. 1991;9:465-76.
20. Gruber R, Mayer C, Bobacz K, Krauth MT, Graninger W, Luyten FP, Erlacher L. Effects of cartilage-derived morphogenetic proteins and osteogenic protein-1 on osteochondrogenic differentiation of periosteum-derived cells. Endocrinology. 2001; 142:2087-94. (Pubitemid 32405968)
21. Zhang X, Xie C, Lin AS, Ito H, Awad H, Lieberman JR, Rubery PT, Schwarz EM, O'Keefe RJ, Guldberg RE. Periosteal progenitor cell fate in segmental cortical bone graft transplantations: Implications for functional tissue engineering. J Bone Miner Res. 2005;20:2124-37. (Pubitemid 41698776)
22. Colnot C. Skeletal cell fate decisions within periosteum and bone marrow during bone regeneration. J Bone Miner Res. 2009; 24:274-82.
23. Brighton CT, Hunt RM. Early histological and ultrastructural changes in medullary fracture callus. J Bone Joint Surg Am. 1991;73:832-47.
24. Schor AM, Allen TD, Canfield AE, et al. Pericytes derived from the retinal microvasculature undergo calcification in vitro. J Cell Sci. 1990;97:449-61. (Pubitemid 20374486)
25. Brighton CT, Lorich DG, Kupcha R, et al. The pericyte as a possible osteoblast progenitor cell. Clin Orthop. 1992; 275:287-99.
26. Diaz-Flores L, Gutierrez R, Lopez-Alonso A, et al. Pericytes as a supplementary source of osteoblasts in periosteal osteogenesis. Clin Orthop. 1992;275:280-6.
27. Doherty MJ, Ashton BA, Walsh S, et al. Vascular pericytes express osteogenic potential in vitro and in vivo. J Bone Miner Res. 1998;13:828-83.
28. Tintut Y, Alfonso Z, Saini T, et al. Multilineage potential of cells from the artery wall. Circulation. 2003;108:2505-10. (Pubitemid 37444413)
29. Farrington-Rock C, Crofts NJ, Doherty MJ, Ashton BA, Griffin- Jones C, Canfield AE. Chondrogenic and adipogenic potential of microvascular pericytes. Circulation. 2004;110:2226-32. (Pubitemid 39372506)
30. Gerber HP, Vu TH, Ryan AM, Kowalski J, Werb Z, Ferrara N. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med. 1999;5:623-8. (Pubitemid 29289424)
31. Lee JY, Qu-Petersen Z, Cao B, Kimura S, Jankowski R, Cummins J, Usas A, Gates C, Robbins P, Wernig A, Huard J. Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing. J Cell Biol. 2000;150:1085-100.
32. Usas A, Huard J. Muscle-derived stem cells for tissue engineering and regenerative therapy. Biomaterials. 2007;28:5401-6. (Pubitemid 47599647)
33. Kuznetsov SA, Mankani MH, Gronthos S, Satomura K, Bianco P, Robey PG. Circulating skeletal stem cells. J Cell Biol. 2001;153:1133-40.
34. Zvaifler NJ, Marinova-Mutafchieva L, Adams G, Edwards CJ, Moss J, Burger JA, Maini RN. Mesenchymal precursor cells in the blood of normal individuals. Arthritis Res. 2000;2:477-88. (Pubitemid 32223796)
35. Wang Y, Johnsen HE, Mortensen S, Bindslev L, Sejersten Ripa R, Haack-Sorensen M, Jorgensen E, Fang W, Kastrup J. Changes in circulating mesenchymal stem cells, stem cell homing factor, and vascular growth factors in patients with acute ST elevation myocardial infarction treated with primary percutaneous coronary intervention. Heart. 2006;92:768-74. (Pubitemid 43799209)
36. Campagnoli C, Roberts IA, Kumar S, Bennett PR, Bellantuono I, Fisk NM. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood. 2001;98:2396-402.
37. Erices A, Conget P, Minguell JJ. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol. 2000;109:235-42. (Pubitemid 30340601)
38. Huss R, Lange C, Weissinger EM, Kolb HJ, Thalmeier K. Evidence of peripheral blood-derived, plastic-adherent CD34(-/low) hematopoietic stem cell clones with mesenchymal stem cell characteristics. Stem Cells. 2000;18:252-60. (Pubitemid 30602272)
39. Wu GD, Nolta JA, Jin YS, Barr ML, Yu H, Starnes VA, Cramer DV. Migration of mesenchymal stem cells to heart allografts during chronic rejection. Transplantation. 2003;75:679-85. (Pubitemid 36337368)
40. Lazarus HM, Haynesworth SE, Gerson SL, Caplan AI. Human bone marrow-derived mesenchymal (stromal) progenitor cells (MPCs) cannot be recovered from peripheral blood progenitor cell collections. J Hematother. 1997;6:447-55.
41. Wexler SA, Donaldson C, Denning-Kendall P, Rice C, Bradley B, Hows JM. Adult bone marrow is a rich source of human mesenchymal'stem' cells but umbilical cord and mobilized adult blood are not. Br J Haematol. 2003;121:368-74. (Pubitemid 36560606)
42. Kuznetsov SA, Mankani MH, Leet AI, Ziran N, Gronthos S, Robey PG. Circulating connective tissue precursors: Extreme rarity in humans and chondrogenic potential in guinea pigs. Stem Cells. 2007;25:1830-9. (Pubitemid 47121863)
43. Kumagai K, Vasanji A, Drazba J, Butler R, Muschler G. Circulating cells with osteogenic potential are physiologically mobilized into the fracture healing site in the parabiotic mice model. J Orthop Res. 2008;26:165-75. (Pubitemid 351220134)
44. Otsuru S, Tamai K, Yamazaki T, Yoshikawa H, Kaneda Y. Circulating bone marrow-derived osteoblast progenitor cells are recruited to the bone-forming site by the CXCR4/stromal cellderived factor-1 pathway. Stem Cells. 2008;26:223-34.
45. Kitaori T, Ito H, Schwarz EM, Tsutsumi R, Yoshitomi H, Oishi S, Nakano M, Fujii N, Nagasawa T, Nakamura T. Stromal cellderived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model. Arthritis Rheum. 2009;60:813-23.
46. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, Alfonso ZC, Fraser JK, Benhaim P, Hedrick MH. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 2002;13:4279-95. (Pubitemid 35471185)
47. Bi Y, Ehirchiou D, Kilts TM, Inkson CA, Embree MC, Sonoyama W, Li L, Leet AI, Seo BM, Zhang L, Shi S, Young MF. Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche. Nat Med. 2007;13:1219-27. (Pubitemid 47530625)
48. Lavoie JF, Biernaskie JA, Chen Y, Bagli D, Alman B, Kaplan DR, Miller FD. Skin-derived precursors differentiate into skeletogenic cell types and contribute to bone repair. Stem Cells Dev. 2009;18:893-906.
49. Shyu W, Lee Y, Liu D, Lin S, Li H. Homing genes, cell therapy and stroke. Front Biosci. 2006;11:899-907. (Pubitemid 43253445)
50. Liu ZJ, Zhuge Y, Velazquez OC. Trafficking and differentiation of mesenchymal stem cells. J Cell Biochem. 2009;106:984-91.
51. Fox JM, Chamberlain G, Ashton BA, Middleton J. Recent advances into the understanding of mesenchymal stem cell trafficking. Br J Haematol. 2007;137:491-502. (Pubitemid 46817339)
52. Miyasaka M, Tanaka T. Lymphocyte trafficking across high endothelial venules: Dogmas and enigmas. Nat Rev Immunol. 2004;4:360-70. (Pubitemid 38649278)
53. Honczarenko M, Le Y, Swierkowski M, Ghiran I, Glodek AM, Silberstein LE. Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells. 2006;24:1030-41. (Pubitemid 44464736)
54. Chamberlain G, Wright K, Rot A, Ashton B, Middleton J. Murine mesenchymal stem cells exhibit a restricted repertoire of functional chemokine receptors: Comparison with human. PLoS One. 2008;3:e2934.
55. Karp JM, Leng Teo GS. Mesenchymal stem cell homing: The devil is in the details. Cell Stem Cell. 2009;4:206-16.
56. Burger J, Kipps T. CXCR4: A key receptor in the crosstalk between tumor cells and their microenvironment. Blood. 2006;107:1761-7. (Pubitemid 43289351)
57. Lataillade J, Clay D, Dupuy C, Rigal S, Jasmin C, Bourin P, et al. Chemokine SDF-1 enhances circulating CD34(?) cell proliferation in synergy with cytokines: Possible role in progenitor survival. Blood. 2000;95:756-68. (Pubitemid 30062693)
58. Wynn R, Hart C, Corradi-Perini C, O'Neill L, Evans C, Wraith J, et al. A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood. 2004;104:2643-5. (Pubitemid 39434942)
59. Dar A, Goichberg P, Shinder V, Kalinkovich A, Kollet O, Netzer N, et al. Chemokine receptor CXCR4-dependent internalization and resecretion of functional chemokine SDF-1 by bone marrow endothelial and stromal cells. Nat Immunol. 2005;6:1038-46. (Pubitemid 41486189)
60. Kucia M, Ratajczak J, Reca R, Janowska-Wieczorek A, Ratajczak M. Tissue-specific muscle, neural and liver stem/progenitor cells reside in the bone marrow, respond to an SDF-1 gradient and are mobilized into peripheral blood during stress and tissue injury. Blood Cells Mol Dis. 2004;32:52-7. (Pubitemid 38147696)
61. Abbott J, Huang Y, Liu D, Hickey R, Krause D, Giordano F. Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation. 2004;110:3300-5. (Pubitemid 39557491)
62. Ceradini D, Kulkarni A, Callaghan M, Tepper O, Bastidas N, Kleinman M, et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med. 2004;10:858-64. (Pubitemid 39070860)
63. Ji J, He B, Dheen S, Tay S. Interactions of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury. Stem Cells. 2004;22:415-27. (Pubitemid 38736625)
64. Cheng Z, Ou L, Zhou X, Li F, Jia X, Zhang Y, Liu X, Li Y, Ward CA, Melo LG, Kong D. Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance. Mol Ther. 2008;16:571-9. (Pubitemid 351314998)
65. Granero-Moltó F, Weis JA, Miga MI, Landis B, Myers TJ, O'Rear L, Longobardi L, Jansen ED, Mortlock DP, Spagnoli A. Regenerative effects of transplanted mesenchymal stem cells in fracture healing. Stem Cells. 2009;27:1887-98.
66. Belema-Bedada F, Uchida S, Martire A, Kostin S, Braun T. Efficient homing of multipotent adult mesenchymal stem cells depends on FROUNT-mediated clustering of CCR2. Cell Stem Cell. 2008;2:566-75. (Pubitemid 351729213)
67. Wang L, Li Y, Chen X, Chen J, Gautam SC, Xu Y, Chopp M. MCP-1, MIP-1, IL-8 and ischemic cerebral tissue enhance human bone marrow stromal cell migration in interface culture. Hematology. 2002;7:113-7. (Pubitemid 34692996)
68. Hung SC, Pochampally RR, Hsu SC, Sanchez C, Chen SC, Spees J, Prockop DJ. Short-term exposure of multipotent stromal cells to low oxygen increases their expression of CX3CR1 and CXCR4 and their engraftment in vivo. PLoS One. 2007;2:e416.